Approval backed by two Phase 3 clinical studies where RINVOQ (15 mg, once daily) showed efficacy across multiple measures of disease activity in active psoriatic arthritis (PsA) with a safety… Read More
TORONTO, ON – Fasken has joined the Open Cap Table Coalition, along with 27 companies including banks and equity management providers. The Firm is the only Canadian-based international law firm member. The… Read More
Norton Rose Fulbright is the top firm for underwriter’s counsel work in the public finance and bond industry according to Refinitiv‘s US Municipals Review. The firm was ranked number one for… Read More
VICTORIA, BC – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA), a leader in full-service therapeutic antibody discovery and development, today announced financial results for second… Read More
Nine abstracts across Takeda’s hematology portfolio and pipeline demonstrate Takeda’s commitment to patient-centric, innovative care that aims to drive greater treatment outcomes Includes data exploring ADYNOVATE® [Antihemophilic Factor (Recombinant), PEGylated] in… Read More
